Gluten in Medicine Disclosure Act of 2021
Latest action · Apr 9, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 8, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Gluten in Medicine Disclosure Act of 2021
This bill prohibits the sale of any drug intended for human use that contains an ingredient derived from a gluten-containing grain unless the drug's label (1) states that the drug contains such an ingredient, and (2) identifies the type of grain from which the ingredient is derived.
Cosponsors 27
Members who signed on, in the order they did. Signatures ran from Apr 8, 2021 to Sep 3, 2021; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-OH | Steve Stivers | Original | Apr 8, 2021 |
| D-MN | Betty McCollum | May 4, 2021 | |
| D-IL | Bill Foster | May 4, 2021 | |
| R-PA | Brian K. Fitzpatrick | May 4, 2021 | |
| D-ME | Chellie Pingree | May 4, 2021 | |
| D-IA | Cynthia Axne | May 4, 2021 | |
| D-PA | Madeleine Dean | May 4, 2021 | |
| D-CA | Ro Khanna | May 4, 2021 | |
| D-TN | Steve Cohen | May 4, 2021 | |
| D-NY | Thomas R. Suozzi | May 4, 2021 | |
| D-OR | Earl Blumenauer | May 13, 2021 | |
| D-CA | Josh Harder | May 13, 2021 | |
| D-CA | Julia Brownley | May 13, 2021 | |
| D-IL | Bobby L. Rush | May 28, 2021 | |
| D-MD | David J. Trone | May 28, 2021 | |
| D-CA | Doris O. Matsui | May 28, 2021 | |
| D-OR | Kurt Schrader | May 28, 2021 | |
| D-MA | Ayanna Pressley | Jun 8, 2021 | |
| D-PA | Conor Lamb | Jun 8, 2021 | |
| D-FL | Darren Soto | Jun 8, 2021 | |
| D-TN | Jim Cooper | Jun 8, 2021 | |
| D-CA | Ted Lieu | Jun 8, 2021 | |
| R-NY | John Katko | Jun 29, 2021 | |
| D-HI | Kaiali'i Kahele | Jul 22, 2021 | |
| D-CA | Zoe Lofgren | Jul 29, 2021 | |
| D-TX | Colin Z. Allred | Sep 3, 2021 | |
| D-VA | Elaine G. Luria | Sep 3, 2021 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 8, 2021 |
| Health Subcommittee | Referred Apr 9, 2021 |
Actions 3
Everything that happened, newest first.
- Apr 9, 2021Referred to the Subcommittee on Health.
- Apr 8, 2021Introduced in House
- Apr 8, 2021Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 61, April 8, 2021, page H1721.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 2074 | Gluten in Medicine Disclosure Act of 2019 | Reintroduction of | Apr 4, 2019 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.
- Short Title(s) as Introduced
- Gluten in Medicine Disclosure Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Apr 8, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
